National and Kapodistrian University of Athens
Ανοσοϊστοχημικός προσδιορισμός της απόπτωσης και ποσοτική εκτίμηση αυτής σε νεκροτομικό υλικό μυοκαρδίου
Abstract
dc:descriptionOBJECTIVES: Significant progress has been made in demonstrating the role of apoptosis in various heart diseases, and in elucidating the molecular mechanisms of cardiac apoptosis. The progressive loss of cardiac myocytes is one of the most important pathogenic components of the heart failure. Even though the rate of apoptosis in heart failure is relatively low in absolute numbers, it is significantly higher than that in the normal heart, which has essentially negligible baseline apoptosis. Recently, animal models of heart failure incorporating transgenic technology have confirmed that myocyte apoptosis itself is sufficient to induce heart failure. The importance of apoptosis in cardiovascular system is also becoming increasingly clear, and the inhibition of apoptosis is emerging as a potential therapeutic tool for various forms of cardiovascular disease. The purpose of this study was to investigate the presence of apoptosis-related proteins p53, bax, bak, bcl-2 in dilated cardiomyopathy and in ischemic cardiac disorders.METHODS: We studied myocardial samples from 40 hearts with histologic findings of acute myocardial infraction (Group A1), 40 hearts with old myocardial infraction (Group A2), and 40 hearts with dilated cardiomyopathy. Myocardial samples from 30 normal hearts were used as control group. An immunohistochemical method was performed with the use of p53, bax, bak, bcl-2 and bcl-xl antibodies.RESULTS: Immunohistochemistry of proapoptotic proteins (p53, bax, bak) and antiapoptotic proteins (Bcl-2, bcl-xl) demonstrated higher levels of these proteins in dilated cardiomyopathy as compared with normal hearts. The diseased group had a larger number of samples with strong p53, bax, bak, staining (50%, 58%, 55%, respectively) as compared with the control group, in which demonstrated weak p53 staining (46%, 50%, 43%, respectively). Bcl-2 and bcl-xl immunostaining in the positive samples of the diseased group was generally weak (70%, 68%, respectively) and negative in the control group (60%, 65%, respectively). Furthermore, antiapoptotic proteins (Bcl-2, bcl-xl) are induced in salvaged myocytes surrounding infracted areas in the regions at risk in acute stage of infraction. Bcl-2 positive myocytes were not seen in the infracted myocytes in the heart with acute infraction. Bcl-2 and bcl-xl immunostaining in salvaged myocytes of163hearts with old infraction was generally weak. Bcl-2 positive immunoreactivity was not evident in normal hearts. Proapoptotic protein expression (p53, bax, bak) was rare in salvaged myocytes within the risk area at the acute stage of infraction. P53, bax and bak positive immunoreactivity was evident in the infracted myocytes. Proapoptotic proteins are induced in salvaged myocytes at the old stage of infraction. P53 positive immunoreactivity of normal control heart tissue was slight in most of myocytes. Myocytes exposed to various stress, such as chronic ischemia (salvaged myocytes at the old stage of infraction) induced the overexpression of proapoptotic proteins.CONCLUSIONS: The elevated presence of p53, bax and bak -positive cells in dilated cardiomyopathy is associated with progressive loss of myocytes in heart failure. On the other hand, increased expression of the antiapoptotic protein bcl-2 in human myocardium with dilated cardiomyopathy may be a compensation for the loss of myocytes and a possible compensatory antiapoptotic mechanism in the diseased group. Furthermore, the elevated expression of proapoptotic proteins is associated with the progressive loss of myocytes by apoptosis and may play a role in the evolution of the chronic heart failure in patients with old myocardial infraction and chronic ischemic disease. The increased expression of antiapoptotic proteins in acute myocardial infraction represents a possible compensatory mechanism of salvaged myocytes. The prevalence of the apoptotic mechanism or this of compensatory antiapoptotic may influence the evolution of heart failure in heart diseases.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsipis, Angelos
- Τσίπης, Άγγελος
Subjects
dc:subject × 20- Απόπτωση
- Έμφραγμα μυοκαρδίου
- Διατατική μυοκαρδιοπάθεια
- Αντιαποπτωτικές πρωτεΐνες
- Προαποπτωτικές πρωτεΐνες
- Ανοσοϊστοχημεία
- Καρδιακή ανεπάρκεια
- Νεκροτομή
- Apoptosis
- Ischemic cardiac disorders
- Dilated cardiomyopathy
- Antiapoptotic proteins
- Proapoptotic proteins
- Immunohistochemistry ( IHC)
- Heart failure
- Autopsy
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29669